
HTG Molecular Diagnostics (NASDAQ:HTGM) brought in sales totaling $2.88 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 15.6%, resulting in a loss of $5.19 million. HTG Molecular Diagnostics collected $2.52 million in revenue during Q3, but reported earnings showed a $4.49 million loss.